Security key
171077407
Niagen Bioscience, Inc. - Common Stock (NAGE)
CUSIP: 171077407
Q2 2023 13F Holders as of 30 Jun 2023
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 79,963,455
- Total 13F shares
- 11,256,922
- Share change
- -595,947
- Total reported value
- $17,672,233
- Put/Call ratio
- 30%
- Price per share
- $1.57
- Number of holders
- 55
- Value change
- -$922,792
- Number of buys
- 17
- Number of sells
- 24
Report period
Q2 2023
Institutions
55
Top holders
10
NAGE full security history
Newer quarter: Q3 2023
Previous quarter: Q1 2023
Niagen Bioscience, Inc. SEC filings
Niagen Bioscience, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 171077407
Recent filing periods:
Top shareholders of NAGE - Niagen Bioscience, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
3.9%
|
3,128,018
|
$4,785,867 | — | 31 Mar 2023 | |
| Tieton Capital Management, LLC |
13F
|
Company |
3.2%
|
2,548,710
|
$3,900,000 | — | 31 Mar 2023 | |
| ICONIQ Capital, LLC |
13F
|
Company |
1.6%
|
1,296,354
|
$1,983,422 | — | 31 Mar 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.1%
|
901,196
|
$1,378,830 | — | 31 Mar 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
557,435
|
$852,875 | — | 31 Mar 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.64%
|
512,912
|
$785,000 | — | 31 Mar 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.53%
|
427,200
|
$654,000 | — | 31 Mar 2023 | |
| GMT CAPITAL CORP |
13F
|
Company |
0.37%
|
296,905
|
$454,265 | — | 31 Mar 2023 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.26%
|
209,992
|
$321,288 | — | 31 Mar 2023 | |
| Cambridge Investment Research Advisors, Inc. |
13F
|
Company |
0.24%
|
194,558
|
$298,000 | — | 31 Mar 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.24%
|
190,239
|
$291,066 | — | 31 Mar 2023 | |
| GAMCO INVESTORS, INC. ET AL |
13F
|
Company |
0.22%
|
176,550
|
$270,122 | — | 31 Mar 2023 | |
| GABELLI FUNDS LLC |
13F
|
Company |
0.2%
|
156,800
|
$239,904 | — | 31 Mar 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.14%
|
108,947
|
$166,689 | — | 31 Mar 2023 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.13%
|
103,742
|
$159,000 | — | 31 Mar 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.12%
|
96,013
|
$146,900 | — | 31 Mar 2023 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
94,979
|
$145,318 | — | 31 Mar 2023 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.11%
|
86,882
|
$132,929 | — | 31 Mar 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.11%
|
84,090
|
$129,000 | — | 31 Mar 2023 | |
| Cowen Prime Advisors LLC |
13F
|
Company |
0.1%
|
79,557
|
$105,000 | — | 31 Mar 2023 | |
| OneDigital Investment Advisors LLC |
13F
|
Company |
0.07%
|
55,042
|
$84,214 | — | 31 Mar 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
0.06%
|
45,688
|
$69,903 | — | 31 Mar 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
0.05%
|
39,300
|
$61,000 | — | 31 Mar 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.04%
|
34,600
|
$52,938 | — | 31 Mar 2023 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.04%
|
30,100
|
$46,053 | — | 31 Mar 2023 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.03%
|
27,600
|
$42,228 | — | 31 Mar 2023 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.03%
|
26,800
|
$41,000 | — | 31 Mar 2023 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.03%
|
24,667
|
$37,741 | — | 31 Mar 2023 | |
| AXXCESS WEALTH MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
22,834
|
$34,936 | — | 31 Mar 2023 | |
| Crestwood Advisors Group, LLC |
13F
|
Company |
0.03%
|
22,023
|
$33,695 | — | 31 Mar 2023 | |
| Kestra Advisory Services, LLC |
13F
|
Company |
0.03%
|
21,000
|
$32,130 | — | 31 Mar 2023 | |
| Midwest Professional Planners, LTD. |
13F
|
Company |
0.03%
|
20,950
|
$32,054 | — | 31 Mar 2023 | |
| INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
20,000
|
$30,600 | — | 31 Mar 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.02%
|
19,144
|
$29,290 | — | 31 Mar 2023 | |
| LPL Financial LLC |
13F
|
Company |
0.02%
|
18,915
|
$28,940 | — | 31 Mar 2023 | |
| Squarepoint Ops LLC |
13F
|
Company |
0.02%
|
17,983
|
$27,514 | — | 31 Mar 2023 | |
| UBS Group AG |
13F
|
Company |
0.02%
|
17,615
|
$26,951 | — | 31 Mar 2023 | |
| Virtu Financial LLC |
13F
|
Company |
0.02%
|
17,377
|
$27,000 | — | 31 Mar 2023 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
16,469
|
$25,198 | — | 31 Mar 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.02%
|
15,383
|
$23,536 | — | 31 Mar 2023 | |
| Snowden Capital Advisors LLC |
13F
|
Company |
0.02%
|
15,000
|
$22,950 | — | 31 Mar 2023 | |
| Federation Des Caisses Desjardins du Quebec |
13F
|
Individual |
0.02%
|
12,025
|
$18,398 | — | 31 Mar 2023 | |
| Merriman Wealth Management, LLC |
13F
|
Company |
0.01%
|
11,800
|
$18,054 | — | 31 Mar 2023 | |
| MAI Capital Management |
13F
|
Company |
0.01%
|
10,667
|
$16,321 | — | 31 Mar 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.01%
|
10,029
|
$15,344 | — | 31 Mar 2023 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0.01%
|
9,370
|
$14,000 | — | 31 Mar 2023 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
5,350
|
$9,000 | — | 31 Mar 2023 | |
| North Star Investment Management Corp. |
13F
|
Company |
0.01%
|
5,000
|
$7,650 | — | 31 Mar 2023 | |
| Sandy Spring Bank |
13F
|
Company |
0%
|
3,500
|
$5,355 | — | 31 Mar 2023 | |
| WOLFF WIESE MAGANA LLC |
13F
|
Company |
0%
|
3,000
|
$4,590 | — | 31 Mar 2023 |
Institutional Holders of Niagen Bioscience, Inc. - Common Stock (NAGE) as of Q2 2023
As of 30 Jun 2023,
Niagen Bioscience, Inc. - Common Stock (NAGE) was held by
55 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
11,256,922 shares.
The largest 10 holders included
VANGUARD GROUP INC, Tieton Capital Management, LLC, ICONIQ Capital, LLC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, RENAISSANCE TECHNOLOGIES LLC, GMT CAPITAL CORP, MILLENNIUM MANAGEMENT LLC, GAMCO INVESTORS, INC. ET AL, and STATE STREET CORP.
This page lists
55
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2023 vs Q1 2023 Across Filers
Q1 2023 holders
57
Q2 2023 holders
55
Holder diff
-2
| Investor | Q1 2023 Shares | Q2 2023 Shares | Share Diff | Share Chg % | Q1 2023 Value $ | Q2 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.